Site Map

Accuray gets multisystem order from 21st Century Oncology

C4 raises $1.3M for multimodality marker

Misonix highlights Q4, fiscal 2015 revenue growth

Accuray posts Q4, year-end results

PET can detect fast-growing prostate cancer

Current AAA screening strategies may miss the mark

Page 1 of 1